|
[1]
|
Zhou, M., Wang, H., Zeng, X., et al. (2019) Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 394, 1145-1158. [Google Scholar] [CrossRef]
|
|
[2]
|
Keep, R.F., Hua, Y. and Xi, G. (2012) Intracerebral Haem-orrhage: Mechanisms of Injury and Therapeutic Targets. The Lancet Neurology, 11, 720-731. [Google Scholar] [CrossRef]
|
|
[3]
|
王鹏, 刘福增, 殷尚炯, 刘丽娜. 超早期显微手术联合脑室外引流治疗高血压性小脑出血[J]. 国际神经病学神经外科学杂志, 2021, 48(1): 13-16.
|
|
[4]
|
Zheng, H., Chen, C., Zhang, J. and Hu, Z. (2016) Mechanism and Therapy of Brain Edema after Intracerebral Hemorrhage. Cerebrovascular Diseases, 42, 155-169. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Simard, J.M., Woo, S.K., Schwartzbauer, G.T. and Gerzanich, V. (2012) Sulfonylurea Receptor 1 in Central Nervous System Injury: A Focused Review. Journal of Cere-bral Blood Flow & Metabolism, 32, 1699-1717. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Meschia, J.F., Bushnell, C., Boden-Albala, B., et al. (2014) Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals from the American Heart Associa-tion/American Stroke Association. Stroke, 45, 3754-3832. [Google Scholar] [CrossRef]
|
|
[7]
|
Mayer, S.A., Brun, N.C., Broderick, J., et al. (2005) Safety and Feasibility of Recombinant Factor VIIa for Acute Intracerebral Hemorrhage. Stroke, 36, 74-79. [Google Scholar] [CrossRef]
|
|
[8]
|
Zhou, Y., Wang, Y., Wang, J., Stetler, R.A. and Yang, Q.-W. (2014) Inflammation in Intracerebral Hemorrhage: From Mechanisms to Clinical Translation. Progress in Neuro-biology, 115, 25-44. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Chen, Y., Chen, S., Chang, J., et al. (2021) Perihematomal Edema after Intracerebral Hemorrhage: An Update on Pathogenesis, Risk Factors, and Therapeutic Advances. Frontiers in Immunology, 12, Article 740632. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Jha, R.M., Puccio, A.M., Chou, S.H., et al. (2017) Sulfonylurea Receptor-1: A Novel Biomarker for Cerebral Edema in Severe Traumatic Brain Injury. Critical Care Medicine, 45, e255-e264. [Google Scholar] [CrossRef]
|
|
[11]
|
Zusman, B.E., Kochanek, P.M., Bell, M.J., et al. (2021) Cerebrospinal Fluid Sulfonylurea Receptor-1 Is Associated with Intracranial Pressure and Outcome after Pediatric TBI: An Exploratory Analysis of the Cool Kids Trial. Journal of Neurotrauma, 38, 1615-1619. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Ying, X., Chen, M., Zhang, J., Sun, C.-F. and Zhou, J. (2022) Serum Sulfonylurea Receptor-1 as a Biomarker of Clinical Severity and Prognosis in Patients with Traumatic Brain Injury. Clinica Chimica Acta, 528, 65-73. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Dundar, T.T., Abdallah, A., Yurtsever, I., et al. (2020) Serum SUR1 and TRPM4 in Patients with Subarachnoid Hemorrhage. Neurosurgical Review, 43, 1595-1603. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Irvine, H., Male, S., Robertson, J., et al. (2019) Reduced Intrac-erebral Hemorrhage and Perihematomal Edema Volumes in Diabetics on Sulfonylureas. Stroke, 50, 995-998. [Google Scholar] [CrossRef]
|
|
[15]
|
Chang, J.J., Khorchid, Y., Kerro, A., et al. (2017) Sul-fonylurea Drug Pretreatment and Functional Outcome in Diabetic Patients with Acute Intracerebral Hemorrhage. Journal of the Neurological Sciences, 381, 182-187. [Google Scholar] [CrossRef] [PubMed]
|